(Q37902000)

25 August 2017

1 reference

title

Update in tuberculosis and nontuberculous mycobacterial disease 2010. (English)

1 reference

Giovanni Battista Migliori

25 August 2017

0 references

Giovanni Sotgiu

2

0 references

object named as

Giovanni Battista Migliori

series ordinal

3

0 references

author name string

Wing Wai Yew

series ordinal

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

American Journal of Respiratory and Critical Care Medicine

25 August 2017

published in

1 reference

25 August 2017

volume

184

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

180-185

1 reference

Nontuberculous mycobacterial lung diseases

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Future Vaccination Strategies against Tuberculosis: Thinking outside the Box

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

CD4 and CD8 T-cell responses to mycobacterial antigens in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

A functional haplotype in the 3'untranslated region of TNFRSF1B is associated with tuberculosis in two African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Revisiting rates of reactivation tuberculosis: a population-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Tuberculosis contact investigation in low prevalence countries: a European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

XDR tuberculosis in South Africa: old questions, new answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Tuberculosis among health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Rapid molecular detection of tuberculosis and rifampin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

What is the optimal dosage of linezolid in treatment of complicated multidrug-resistant tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Linezolid in the treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Predicting outcomes and drug resistance with standardised treatment of active tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Targeted Delivery of Amikacin into Granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Clinical and operational value of the extensively drug-resistant tuberculosis definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Of Blind Men and Elephants: Making Sense of Extensively Drug-resistant Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Diagnostic Usefulness of a T-cell–Based Assay for Extrapulmonary Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Treatment of tuberculosis: update 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

Encouraging News for Multidrug-resistant Tuberculosis Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201102-0325UP

10.1164/RCCM.201102-0325UP

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference